1 Manfred Kurz, Senior Global Regulatory Affairs Manager, Mylan, on the EU Clinical Trials Regulation
event strap

Manfred Kurz, Senior Global Regulatory Affairs Manager, Mylan, on the EU Clinical Trials Regulation

information we require

please check before submitting



Unfortunately the document is not available at this current time, however if you leave your details we'll get it to you as soon as we can.

Please fill in all the information requested. It is very important you enter this information correctly so we can contact you with the document.

Privacy statement »

Manage your email preferences »

Remember my details Information

Information
Remember my details
We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details

An interview with Manfred Kurz on the EU Clinical Trials Regulation

On 16th April 2014 the new EU Clinical Trials Regulation was adopted, however it will not apply until 2016. This new Regulation replaces a convoluted Clinical Trials Directive and aims to streamline clinical trial applications across the EU, making cross border trials easier.
The Regulation also adopted new Clinical Study Report transparency measures, which have raised questions as to the commercially sensitive information they contain making the Life Sciences industry worried about how the Regulation will work in its final form.

In this report we speak with Manfred Kurz, Senior Global Regulatory Affairs Manager at Mylan, about the new EU Clinical Trials Regulation and whether it is a positive move forward.

Download the report now to hear Manfred's insights on:

  • The new EU Clinical Trials Regulation
  • What the EU has to offer as a location for clinical trials compared with other global destinations
  • The main priorities when conducting a clinical trial
  • ls Regulation and whether it is a positive move forward. 

Join us in London on 9th September at the Clinical Trials Briefing to learn how the new regulation impacts clinical trial processes, from a new one stop portal system, to commercially sensitive information and conducting trials across borders.
 
Download the Ebook to gain your 15% discount. Book now!